highly significantP =0.0005
Both the 300IR and 500IR groups had highly significant improvements in Rhinoconjunctivitis Total Symptom Score (RTSS) vs. placebo at the peak pollen season ( P =0.0005 and 0.0014, respectively), which agreed with improvements in RTSS in the primary evaluations.